Target intelligence / Profile preview

ATP-binding cassette subfamily G member 1 (ABCG1)

Target
ABCG1
Molecular classification
Transporter
01

Overview

ATP-binding cassette subfamily G member 1 (ABCG1) is a half-transporter belonging to the ATP-binding cassette (ABC) transporter superfamily. It functions as a homodimer or heterodimer (typically with ABCG4) to facilitate the ATP-dependent efflux of cholesterol, phospholipids, and oxysterols from cells, particularly to mature high-density lipoprotein (HDL) particles. ABCG1 plays a critical role in maintaining cellular lipid homeostasis, preventing the formation of lipid-laden macrophage foam cells, and protecting against atherosclerosis and cardiovascular diseases. Beyond its cardiovascular role, ABCG1 is implicated in metabolic disorders such as obesity and type 2 diabetes, where it regulates adipogenesis and insulin secretion, as well as in Alzheimer's disease and cancer progression, where its overexpression is linked to chemoresistance and tumor cell stemness. Pharmacological modulation of ABCG1 includes indirect upregulation via liver X receptor (LXR) or retinoic acid receptor (RAR) agonists to promote reverse cholesterol transport, as well as direct or indirect inhibition (e.g., using benzamil or dipyridamole) to sensitize cancer cells to chemotherapy.

Other names
ABCG1ABC8WHITE1ATP-binding cassette sub-family G member 1White protein homologATP-binding cassette transporter 8
02

Mechanism of action

Modulation of cholesterol and lipid efflux via ATP-dependent transport

03

Biological functions

Lipid transportCholesterol homeostasisCholesterol effluxApoptosisCell proliferationOther
04

Disease associations

Cardiovascular diseaseAtherosclerosisObesityDiabetesCancerAlzheimer's diseaseOther
05

Safety considerations

Risk of lipid accumulation in macrophages (foam cell formation) if inhibitedPotential for neurodevelopmental toxicity or neurocognitive impairment due to disrupted brain cholesterol homeostasisRisk of hepatic steatosis or dyslipidemia if upregulated via systemic LXR agonistsPotential to promote adipogenesis and obesity if overexpressed in adipose tissue
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

ABCG1 promoter methylationABCG1 expression levelABCG1-mediated cholesterol efflux capacity (CEC)ABCG1 genotype

Beyond the preview

Go deeper on ATP-binding cassette subfamily G member 1 (ABCG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette subfamily G member 1 (ABCG1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call